State Street’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.2M Buy
4,517,994
+57,237
+1% +$801K ﹤0.01% 1562
2025
Q1
$60.6M Sell
4,460,757
-84,216
-2% -$1.14M ﹤0.01% 1544
2024
Q4
$92.6M Buy
4,544,973
+292,962
+7% +$5.97M ﹤0.01% 1384
2024
Q3
$124M Sell
4,252,011
-182,779
-4% -$5.32M 0.01% 1207
2024
Q2
$103M Sell
4,434,790
-1,889,082
-30% -$43.9M ﹤0.01% 1237
2024
Q1
$130M Buy
6,323,872
+837,924
+15% +$17.2M 0.01% 1148
2023
Q4
$118M Buy
5,485,948
+1,210,620
+28% +$26M 0.01% 1196
2023
Q3
$88.2M Sell
4,275,328
-193,163
-4% -$3.98M ﹤0.01% 1267
2023
Q2
$132M Sell
4,468,491
-122,898
-3% -$3.63M 0.01% 1041
2023
Q1
$106M Sell
4,591,389
-254,421
-5% -$5.86M 0.01% 1150
2022
Q4
$135M Buy
4,845,810
+653,582
+16% +$18.2M 0.01% 980
2022
Q3
$129M Buy
4,192,228
+441,528
+12% +$13.6M 0.01% 959
2022
Q2
$110M Sell
3,750,700
-76,092
-2% -$2.24M 0.01% 1086
2022
Q1
$123M Buy
3,826,792
+799,221
+26% +$25.7M 0.01% 1148
2021
Q4
$135M Buy
3,027,571
+229,437
+8% +$10.2M 0.01% 1072
2021
Q3
$141M Buy
2,798,134
+477,674
+21% +$24.1M 0.01% 1026
2021
Q2
$182M Buy
2,320,460
+303,793
+15% +$23.8M 0.01% 896
2021
Q1
$115M Sell
2,016,667
-50,406
-2% -$2.88M 0.01% 1125
2020
Q4
$173M Sell
2,067,073
-188,526
-8% -$15.8M 0.01% 806
2020
Q3
$80.8M Buy
2,255,599
+10,319
+0.5% +$370K 0.01% 1117
2020
Q2
$54.3M Buy
2,245,280
+555,524
+33% +$13.4M ﹤0.01% 1416
2020
Q1
$29.6M Buy
1,689,756
+87,574
+5% +$1.53M ﹤0.01% 1579
2019
Q4
$27.9M Buy
1,602,182
+10,089
+0.6% +$176K ﹤0.01% 1904
2019
Q3
$24.4M Sell
1,592,093
-393,930
-20% -$6.04M ﹤0.01% 1940
2019
Q2
$41.2M Buy
1,986,023
+311,472
+19% +$6.47M ﹤0.01% 1605
2019
Q1
$38.9M Buy
1,674,551
+150,967
+10% +$3.51M ﹤0.01% 1599
2018
Q4
$31.5M Buy
1,523,584
+632,257
+71% +$13.1M ﹤0.01% 1659
2018
Q3
$19.4M Buy
891,327
+598,203
+204% +$13M ﹤0.01% 2202
2018
Q2
$4.47M Buy
293,124
+160,276
+121% +$2.44M ﹤0.01% 2918
2018
Q1
$2.62M Buy
+132,848
New +$2.62M ﹤0.01% 3061